Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quasor is a medical technology company focused on developing advanced solutions for the treatment of cardiac arrhythmias, particularly atrial fibrillation. The company's primary innovation is a high-resolution mapping and ablation system designed to improve the precision and efficacy of catheter-based cardiac procedures. By integrating sophisticated imaging with therapeutic delivery, Quasor aims to reduce procedure times and improve long-term outcomes for patients suffering from complex heart rhythm disorders. The company is currently advancing its technology through pre-clinical validation and early-stage development phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quasor.